← All trials
NCT06100367
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 30, 2019
- Primary completion
- Dec 31, 2024
- Completion date
- Jul 31, 2025
- First posted
- Oct 25, 2023
- Last posted
- Oct 30, 2023
- Enrollment
- 100
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Changi General HospitalLead sponsor
- Khoo Teck Puat HospitalCollaborator
- National University of SingaporeCollaborator
- Ng Teng Fong General HospitalCollaborator
- Sengkang General HospitalCollaborator
- Singapore General HospitalCollaborator
- Nanyang Technological UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.